AlphaStocks
5.3
Consider Buy

Sotera Health Co (SHC)

As of Sep 20, 2026, Sotera Health Co (SHC) scores 5.3/10 on AlphaStocks' five-model composite, #98 of 168 Health Care stocks. At $19, SHC trades 18% above its model fair value of $16.

Health Care / Health Care Services

S&P MidCap 400

$18.73

Below average on several measures. Research carefully.

Consider Buy

Score based on 4 of 5 models — moderate confidence

Data as of Sep 20, 2026

#98out of 168 in Health Care

Is Sotera Health Co a Good Investment in 2026?

Sotera Health Co (SHC) scores 5.3 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates Sotera Health Co as Strong (7/9). However, the Lynch model rates it Caution. Sotera Health Co currently trades 18% above its estimated fair value of $16. Sotera Health Co ranks #98 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E68.8ROE6.2Market Cap5B

Estimated Fair Value

$15.9318% above

Trading above estimated fair value. P/e of 69x implies high growth expectations. rapid eps growth (75%) partially justifies the premium.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Strong

7/9

Buffett

Caution

Business quality & competitive moat

Graham

Caution

Significantly above fair value

Lynch

Caution

Growth rate vs price (PEG)

Greenblatt

Strong

Earnings yield 8.4% · ROC 39%

Frequently Asked Questions

Is Sotera Health Co (SHC) a good investment?
As of Sep 20, 2026, Sotera Health Co (SHC) scores 5.3/10 on AlphaStocks' five-model composite, #98 of 168 Health Care stocks. At $19, SHC trades 18% above its model fair value of $16. That score is below average, suggesting caution.
What is Sotera Health Co's Piotroski F-Score?
Sotera Health Co's Piotroski F-Score status is Strong. The raw score is 7/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is SHC overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $16, SHC appears overvalued. The stock currently trades 18% above its estimated fair value. Trading above estimated fair value. P/e of 69x implies high growth expectations. rapid eps growth (75%) partially justifies the premium.
How does SHC compare to other Health Care stocks?
Sotera Health Co ranks #98 out of 168 stocks in the Health Care sector, placing it in the top 58% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about SHC?
AlphaStocks evaluates SHC using five proven investment models. Piotroski: Strong; Buffett: Caution; Graham: Caution; Lynch: Caution; Greenblatt Magic Formula: Strong. These models are combined into a single composite score of 5.3/10.

Similar Stocks

DVAMDDGX

Compare SHC with

DVA vs SHCMD vs SHCDGX vs SHC

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer